Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2025-12-26 @ 6:57 PM
Study NCT ID:
NCT01569750
Status:
COMPLETED
Last Update Posted:
2017-08-22
First Post:
2012-03-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin Lymphoma
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-06-14
Start Date Type:
ACTUAL
Primary Completion Date:
2014-09-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-09-04
Completion Date Type:
ACTUAL
First Submit Date:
2012-03-30
First Submit QC Date:
None
Study First Post Date:
2012-04-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-18
Last Update Post Date:
2017-08-22
Last Update Post Date Type:
ACTUAL